Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Imperial College London
Fred Hutchinson Cancer Center